Odyssey Therapeutics, Inc. (ODTX) stock
Close on Nov 11, 2026Market cap $1.01BP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Sep 30, 2026
Valuation
- Market cap
- $1.01B
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 2.68
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Book value per share
- $7.83
- Diluted shares
- 48M
Trading
- Previous close
- $20.00
- Open
- $19.98
- Day's range
- $19.22 – $21.21
- Volume
- 245,072
- Average volume (20 days)
- 309,644
- RSI (14 days)
- 56.6
- Volatility (1 year)
- 71.4%
- Relative volume
- 0.87×
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | ODTX | S&P 500 | Difference | ODTX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +10.5% | -2.4% | +12.9 pts | ||
| 3 months | +3.1% | -1.2% | +4.3 pts |
Two years at a glance
Fiscal years 2024 to 2025, USD
Press releases
Releases Odyssey Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- Update
- Results
- Update
Odyssey Therapeutics stock: common questions
What is Odyssey Therapeutics's stock price?
ODTX closed at $20.99 on Nov 11, 2026, up 4.95% on the day.
What is Odyssey Therapeutics's market cap?
Odyssey Therapeutics was worth $1.01B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
Does Odyssey Therapeutics pay a dividend?
No. Odyssey Therapeutics has not paid a cash dividend over the last twelve months.
How many ODTX shares are sold short?
3M shares were sold short at the latest FINRA report, 8.67% of the float, or 15.4 days of average trading volume.
Who are Odyssey Therapeutics's competitors?
Companies most similar to Odyssey Therapeutics by business, industry and size include AMGN, GILD, MRNA, BIIB, BNTX.
See a number that looks wrong?